AAAAAA
Results:
1-15
|
Results: 15
Authors:
Weiss, JM
Oltmanns, K
Gurke, EM
Polack, S
Eick, F
Felberbaum, R
Diedrich, K
Ortmann, O
Citation: Jm. Weiss et al., Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells, EUR J ENDOC, 144(6), 2001, pp. 677-685
Authors:
Nikolettos, N
Al-Hasani, S
Felberbaum, R
Demirel, LC
Kupker, W
Montzka, P
Xia, YX
Schopper, B
Sturm, R
Diedrich, K
Citation: N. Nikolettos et al., Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders, EUR J OB GY, 97(2), 2001, pp. 202-207
Authors:
Diedrich, K
Frydman, R
Devroey, P
Felberbaum, R
Schally, AV
Reissmann, T
Engel, J
Citation: K. Diedrich et al., Comment on the debate article: Embryo implantation: the Rubicon for GnRH antagonists, HUM REPR, 16(6), 2001, pp. 1305-1306
Authors:
Weiss, JM
Felberbaum, R
Ludwig, M
Diedrich, K
Citation: Jm. Weiss et al., Treatment of disturbed ovarian function. Ovarian stimulation and substitution, GYNAKOLOGE, 34(7), 2001, pp. 641-648
Authors:
Ludwig, M
Finas, A
Katalinic, A
Strik, D
Kowalcek, I
Schwartz, P
Felberbaum, R
Kupker, W
Schopper, B
Al-Hasani, S
Diedrich, K
Citation: M. Ludwig et al., Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support, ACT OBST SC, 80(6), 2001, pp. 574-582
Authors:
Gliemroth, J
Knopp, U
Kehler, U
Felberbaum, R
Nowak, G
Citation: J. Gliemroth et al., HELLP syndrome with haemaglobin vasospasm, J CL NEUROS, 7(1), 2000, pp. 59-62
Authors:
Nikolettos, N
Al-Hasani, S
Felberbaum, R
Demirel, LC
Riethmuller-Winzen, H
Reissmann, T
Schopper, B
Sturm, R
Diedrich, K
Citation: N. Nikolettos et al., Comparison of cryopreservation outcome with human pronuclear stage oocytesobtained by the GnRH antagonist, Cetrorelix, and GnRH agonists, EUR J OB GY, 93(1), 2000, pp. 91-95
Authors:
Ludwig, M
Strik, D
Felberbaum, R
Al-Hasani, S
Diedrich, K
Citation: M. Ludwig et al., No significant leukocytosis under controlled ovarian stimulation using theLHRH antagonist Cetrorelix and recFSH, EUR J OB GY, 89(2), 2000, pp. 177-179
Authors:
Felberbaum, R
Diedrich, K
Citation: R. Felberbaum et K. Diedrich, Sicca syndrome and hormonal replacement therapy, GYNAKOLOGE, 33(6), 2000, pp. 391-392
Authors:
Felberbaum, R
Citation: R. Felberbaum, Pelvic and paraaortic lymphomodectomy in ovarian cancer, GYNAKOLOGE, 33(5), 2000, pp. 380-380
Authors:
Felberbaum, R
Dahncke, W
Citation: R. Felberbaum et W. Dahncke, The German IVR Registry as a quality assurance tool and for use in patientcounseling, GYNAKOLOGE, 33(11), 2000, pp. 800-811
Authors:
Keck, C
Felberbaum, R
Citation: C. Keck et R. Felberbaum, Application of Cetrorelix - A GnRH-antagonist in reproductive medicine, GEBURTSH FR, 60(4), 2000, pp. 212-217
Authors:
Felberbaum, R
Citation: R. Felberbaum, Revival of spontaneous cycle for IVF through of the new GnRH antagonist Cetrorelix. Resultatate of a pilot study with minimal ovarian stimulation, GYNAKOLOGE, 32(6), 1999, pp. 492-493
Authors:
Husstedt, W
Felberbaum, R
Bauer, O
Montzka, P
Kupker, W
Diedrich, K
Citation: W. Husstedt et al., Emergency cerclage in the second trimester of pregnancy, GEBURTSH FR, 59(9), 1999, pp. 440-445
Authors:
Weiss, JM
Felberbaum, R
Montzka, P
Ludwig, M
Strik, D
Bals-Pratsch, M
Al-Hasani, S
Ortmann, O
Diedrich, C
Diedrich, K
Citation: Jm. Weiss et al., Concomitant midcyclic GnRH antagonist treatment (Ganirelix) at different dosages, GEBURTSH FR, 59(5), 1999, pp. 209-214
Risultati:
1-15
|